Quality of Life and Surgery in Diverticular Disease

Sponsor
University of Aarhus (Other)
Overall Status
Recruiting
CT.gov ID
NCT05393609
Collaborator
Randers Regional Hospital (Other)
250
1
34.3
7.3

Study Details

Study Description

Brief Summary

Diverticular disease is one of the most common diseases of the gastrointestinal tract in industrial countries. Prevalence and admission rate due to diverticular disease increases.

Symptomatic patients usually present with acute uncomplicated or complicated diverticulitis. Recurrence rates of complicated diverticulitis are estimated to 10-30%. Recurrences, chronic complications or persisting pain, here collectively referred to as chronic diverticular disease, may be treated by elective sigmoidectomy. Currently, there is no specific criteria for elective surgery, but only a recommendation of a tailored approach depending on the patient's symptoms.

It is well established that diverticular disease has a negative impact on quality of life (QoL). Elective laparoscopic sigmoidectomy may increase QoL.

In this prospective study, we will prospectively examine QoL, patient-related outcomes and peri- and postoperative outcome of elective sigmoidectomy for chronic diverticular disease, and compare it to conservatively treated patients.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Sigmoidectomy
  • Dietary Supplement: Conservative

Detailed Description

Design: Prospective, multicentre, observational

Locations: Hospitals in Central and Northern Denmark Region (6 hospitals).

Time: Recruitment starts in April 2022 and is planned to be completed in 2024.

Patients: All patients referred to a surgical clinic due to chronic diverticular disease.

Allocation for surgery or conservative treatment: Patients will be treated according to Danish National Guidelines for treatment of diverticular disease. The study will not influence the treatment of the patient, but only observe and evaluate current daily practice.

Intervention: Patients will be asked to answer questionnaires at inclusion and again after 1 year. Patients treated with sigmoidectomy will also be asked to answers questionnaires 3 weeks and 3 months after surgery.

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
250 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Quality of Life and Surgery in Diverticular Disease
Actual Study Start Date :
Apr 22, 2022
Anticipated Primary Completion Date :
Mar 1, 2025
Anticipated Study Completion Date :
Mar 1, 2025

Arms and Interventions

Arm Intervention/Treatment
Sigmoidectomy

Patients with diverticular disease undergoing elective resection of the sigmoid colon

Procedure: Sigmoidectomy
Conventional laparoscopic resection of the sigmoid colon

Conservative

Patients with diverticular disease not referred to surgery, but conservative treatment

Dietary Supplement: Conservative
According to current practice including advice on supplementary dietary fiber, analgetics, or laxatives when indicated.

Outcome Measures

Primary Outcome Measures

  1. Health related quality of life [Change from baseline to 1 year follow-up.]

    Gastrointestinal Quality of Life (GIQLI) 36 items. Total score 0-144 (0=worst, 144=best).

  2. Disease-specific quality of life [Baseline.]

    Diverticulitis quality of life (DV-QoL) 16 items. Total score 0-10 (0= best,10=worst).

Secondary Outcome Measures

  1. Generic quality of life [Change from baseline to 3 weeks follow-up, 3 months follow-up and 1 year follow-up.]

    EuroQol-5 Domain 5-level (EQ-5D-5L) 5 items. Total score 5-25 (5=best. 25 = worst). Visual analog scale 0-100 (0=worst, 100= best).

  2. Bowel function [Change from baseline to 3 weeks follow-up, 3 months follow-up and 1 year follow-up.]

    Patient-assessment of constipation symptoms (PAC-SYM) 12 items. Total score 0-50 (0=best, 50=worst).

  3. Bowel function [Change from baseline to 3 weeks follow-up, 3 months follow-up and 1 year follow-up.]

    Low anterior resection syndrome score (LARS score) 5 items. Total score 0-42 (0=best, 42=worst).

  4. Pain related to diverticular disease [Change from baseline to 3 weeks follow-up, 3 months follow-up and 1 year follow-up.]

    Modified Rectal Cancer Pain Score 7 items. Total score 0-45 (0= best, 45= worst). 7 item. Total score 0-29 (0= worst, 65= best).

  5. Urinary dysfunction - females [Change from baseline to 3 weeks follow-up, 3 months follow-up and 1 year follow-up.]

    International Consultation on Incontinence Questionnaire Female Lower Urinary Tract Symptoms (CIQ-FLUTS) 13 items. Total score 0-52 (0=best, 52=worst).

  6. Urinary dysfunction - males [Change from baseline to 3 weeks follow-up, 3 months follow-up and 1 year follow-up.]

    International Consultation on Incontinence Questionnaire Male Lower Urinary Tract Symptoms (ICIQ-MLUTS) 14 items. Total score 0-56 (0=best, 56=worst).

  7. Sexual dysfunction - females [Change from baseline to 3 weeks follow-up, 3 months follow-up and 1 year follow-up.]

    Modified Rectal Cancer Female Sexuality Score 7 items. Total score 0-29 (0=best, 29= worst). 14 item. Total score 0-56 (0=best, 56=worst).

  8. Sexual dysfunction - males [Change from baseline to 3 weeks follow-up, 3 months follow-up and 1 year follow-up.]

    The International Index of Erectile Function Questionnaire (IIEF) 15 items. Total score 0-65 (0= worst, 65= best).

  9. Postoperative morbidity [30 days]

    Postoperative complications classified according to the Clavien-Dindo classification

  10. Postoperative mortality [30 days]

    Mortality within the postoperative period

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Referred to surgical clinic due to diverticular disease

  • Colonic diverticula verified by CT or endoscopy

Exclusion Criteria:
  • Previous colonic resection other than appendectomy

  • Previous or current colorectal cancer

  • Previous or current disseminated cancer

  • Inflammatory bowel disease

  • Psychiatric disorder influencing the ability to answer questionnaires

  • Inadequate Danish

Contacts and Locations

Locations

Site City State Country Postal Code
1 Randers Regional Hospital Randers Central Denmark Region Denmark 8930

Sponsors and Collaborators

  • University of Aarhus
  • Randers Regional Hospital

Investigators

  • Principal Investigator: Helene R Dalby, MD, Randers Regional Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Aarhus
ClinicalTrials.gov Identifier:
NCT05393609
Other Study ID Numbers:
  • Life with diverticular disease
First Posted:
May 26, 2022
Last Update Posted:
May 26, 2022
Last Verified:
Apr 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 26, 2022